DECODING TO DISCOVER

Our mission is to empower hospitals and researchers around the globe to uncover clinically relevant information within the genome, to close the gap from bench to bedside and improve the lives of patients worldwide.

  • Hospitals
  • Diagnostic Labs
  • Researchers

Meet Genome Explorer®

Your genomic analysis and clinical decision support platform

EMPOWERING PRECISION MEDICINE

Across our portfolio of products, services, customizable pipelines and reports, Genome International provides clinical decision support tools, revealing crucial information about druggable genes, adverse drug reactions, clinical trials, and more.

OUR WHOLE-GENOME TECHNOLOGIES

Our team has developed many novel technologies to uncover the clinical hotspots in the whole human genome. Unlike traditional software that only focus on the coding regions of genes which comprise less than 2% of the genome, our software targets 100% of the genome, including both coding and non-coding regions. Our methodologies enable scientists to discover the genetic causes of diseases and drug responses throughout the human genome.

INTELLIGENT WORKFLOW

Customized objective-driven workflows support all NGS experimental strategies with intelligent secondary and tertiary genomic analysis. The interpretations are based on our scientifically-validated proprietary algorithms and from our integrated knowledge base.

SEQUENCING TO DECISION SUPPORT

Genome Explorer performs rapid analysis of the whole genome data and provides an accurate and intuitive clinical report for quick understanding by clinicians. Our platform obtains the patient sequence data from any location, and performs a fast and accurate analysis, enabling clinicians to visualize the results from the patient’s EHR by the touch of a button.

dna in hands

GET THE POWER OF THE GENOME IN THE PALM OF YOUR HAND

Learn More

Cancer Diagnosis and Therapeutics

Identify somatic and germline mutations, Gene Fusion events, CNVs and Structural Variants. Transforms tumor DNA to a clinical report in accordance with NCCN, ASCO & ESMO guidelines with FDA approved drugs, dosage, drug adverse effects and relevant clinical trials.

Inherited Disorders

Sequence and discover genetic germline candidate mutations from various Mendelian disorders with inbuilt standard inherited disorder panels. The significant mutations are reported in accordance with ACMG/AMP guidelines and have up-to-date information from all relevant annotation sources.
Clients & Partners